✦ LIBER ✦

HCV RNA monitoring for tailored regimens of interferon therapy in hepatitis C

✍ Scribed by K Kanai; M Kako; T Aikawa; T Kumada; T Kawasaki; T Hatahara; Y Oka; M Mizokami; T Sakai; K Iwata; H Okamoto; M Mayumi; S Mishiro

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quantitative HCV RNA and effect of inter

✍ G. Yamada; M. Takahashi; T. Tsuji; H. Yoshizawa; H. Okamoto 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 184 KB

Improved endpoint determination of inter

✍ Brouwer, J.T.; Kleter, G.E.M.; Quint, W.G.V.; Heijtink, R.A.; Schaim, S.W. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Prospective study of interferon (IFN) th

✍ Shiratori, Y; Yokosuka, O; Nakata, R; Ihori, M; Hirota, K; Katamoto, T; Unuma, T 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Therapeutic efficacy of interferon of HC

✍ Kuroki, T. ;Nishiguchi, S. ;Ueda, T. ;Yabusako, T. ;Fukuda, K. ;Takeda, T. ;Kim, 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 307 KB

Hepatic HCV-RNA as a predictor of outcom

✍ MASAAKI KONDO; KATSUAKI TANAKA; MASANORI IKEDA; SHINJU ARATA; SATORU SAITO; TAKA 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 586 KB

P-279 Changes of hepatitis C virus (HCV)

✍ H Matsumoto; T Yamaguchi; Y Chuganji; M Momoi 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 101 KB